Adverum Biotechnologies Inc
ADVM
Get informed when a big investor buys or sells
+ FollowMarket Cap$96.26M
Close$
$-1.63
137.4% downside
Current Fair Value
137.4% downsideOvervalued by 137.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $96.26 Million |
|---|---|
| Enterprise Value | $159.14 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-6.62 |
| Beta | 0.87 |
| Outstanding Shares | 23,487,000 |
Return
| Return on Equity | 317.59% |
|---|---|
| Return on Assets | -244.12% |
| Return on Invested Capital | -498.24% |
Valuation & Multiples
| P/E Ratio | -0.5 |
|---|---|
| PEG | -0.66 |
| Price to Sales | -4.36 |
| Price to Book Ratio | -1.45 |
| Enterprise Value to Revenue | -44.2 |
| Enterprise Value to EBIT | -1.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.56 |
| Debt to Equity | -1.6 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 12, 2025
EPS Estimate
$-1.80
Average shareholder expectationRevenue Estimate
$200,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.2946▲ 129.46% |
|---|---|
| Total Calls | 24,100▲ Infinity% |
| Total Puts | 31,200▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 64.57%▲ 0.30% |
|---|---|
| Total Invested | $61.46M▲ 111.66% |
| Investors Holding | 50▼ 7.00% |
ESG Score
No data
About Adverum Biotechnologies Inc
CEO: Leone Patterson